S 18986

Drug Profile

S 18986

Alternative Names: S 18986-1; S18986

Latest Information Update: 09 Dec 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cortex Pharmaceuticals
  • Developer Servier
  • Class Antidementias; Benzothiadiazines; Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action AMPA receptor modulators; Central nervous system stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Cognition disorders

Most Recent Events

  • 15 Nov 2010 Suspended - Phase-II for Cognition disorders in France (PO)
  • 07 Nov 2007 Pharmacodynamics data from a preclinical trial in cognitive impairment presented at the 37th Annual Meeting of the Society for Neuroscience (SFN-2007) ,
  • 29 Jul 2004 Pharmacodynamics and pharmacokinetics data presented at the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2004) ,,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top